Addiction Medicine Practice

What Addiction Medicine Practice does

Addiction Medicine Practice is a privately held, single-location medication-assisted treatment (MAT) medical practice headquartered in Merchantville, New Jersey, founded in 1996 by Dr. Lance Gooberman. The practice treats individuals addicted to opiates (heroin, prescription painkillers, methadone, fentanyl), alcohol, cocaine, methamphetamine, nicotine, and process addictions (gambling, sex), and recently expanded to food addiction/cravings. Service delivery rests on three core modalities: Suboxone/buprenorphine maintenance, medically supervised detoxification, and naltrexone therapy offered as oral prescriptions, monthly injectable Vivitrol, and surgically implanted pellets. Its proprietary technology is a patented subcutaneous naltrexone pellet formulation (US Patent No. 6,203,813, granted to Dr. Gooberman) delivering 2-3 months of extended-release opioid blockade, supplemented by an in-house compounded naltrexone nasal spray used as a fentanyl overdose antidote and provided free to patients.

The practice operates on a strict cash-pay model: fees are collected in full at time of service via credit card, certified check, or money order, with no acceptance of personal checks, Medicare, Medicaid, or private insurance. Published pricing ranges from $150 for an office consultation, $300-$375 for detoxification, $100-$300/month for maintenance medications, and $400-$600 every 2-3 months for pellet implants, with Vivitrol marked at $1,250/month cash or $100/month insured. Go-to-market is direct-to-consumer via earned media (Wired Magazine, CBS 48 Hours, NBC, MTV), physician and attorney referrals, patient testimonials, and community outreach through NA and recovery networks. Patient acquisition extends beyond the Philadelphia/South Jersey region, with documented patients traveling from England and the U.S. West Coast, despite the practice maintaining only one physical site.

The operation is small (1-10 total employees, 7+ named physicians with board certifications across addiction medicine, OB/GYN, family medicine, pathology, surgery, and internal medicine) and carries meaningful regulatory baggage: in 1999-2002, the New Jersey Attorney General filed civil malpractice charges tied to seven patient deaths during rapid opiate detoxification, ultimately settled for $375,500 plus $30,000 to families, with Dr. Gooberman's medical license revoked for two years. The practice resumed operations and continues to publish service offerings, but has not executed the 2002-stated ambitions to license its pellet procedure to other specialists or raise approximately $5 million for FDA approval of commercial pellet sales, leaving expansion optionality unfulfilled.

Name

Addiction Medicine Practice

Legal name

Addiction Medicine Practice

Website

https://addictionmedicinepractice.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

1–10 employees

Short description

Addiction Medicine Practice is a private, single-location Merchantville, NJ medical practice providing medication-assisted treatment (Suboxone maintenance, naltrexone therapy, detoxification) for individuals with opiate, alcohol, stimulant, nicotine, and process addictions, operating on a cash-pay model using Dr. Gooberman's patented naltrexone pellet implant.

Ownership category

akta.pro rank

Product category

Addiction Medicine / Substance Abuse Treatment

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Physicians, Mental Health Specialists (621112)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro industry

PRIMARYHLAFACAG

Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs)

Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment

SECONDARYHLAFACAF

Outpatient Substance Use Treatment Programs (IOP/PHP/OP)

Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment

SECONDARYHLAFACAE

Residential Substance Use Rehabilitation (Inpatient Rehab)

Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment

SECONDARYBPAGAEAO

Substance Use Recovery & Harm Reduction Support Services

Business & Public Services/Nonprofit, NGO & Social Services/Social Services & Community Support (Food, Housing, Family)

Keywords

• Addiction medicine
• Opioid treatment
• Medication-assisted treatment
• Naltrexone therapy
• Substance abuse treatment

Headquarters

HQ city

Merchantville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Office Consultations: Initial patient consultations for addiction assessment and treatment planning.
2. Detoxification Services: Opiate and alcohol detoxification procedures including medically supervised withdrawal management.
3. Medication-Assisted Maintenance Therapy: Ongoing prescription and administration of Suboxone, naltrexone (oral, injectable, implants), disulfiram, and other addiction medications with monthly follow-up appointments.
4. Naltrexone Pellets/Implants: Surgical implantation of naltrexone pellets providing 2-3 months of extended-release therapy. Priced per implant with repeat procedures.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Addiction Medicine Practice is a physician-owned outpatient addiction medicine clinic in Merchantville, NJ that provides medication-assisted treatment and detoxification services for opioid, alcohol, stimulant, nicotine, and process addictions. Its core offering is direct delivery of MAT programs—including Suboxone/Subutex maintenance, naltrexone therapy (oral, injectable, and proprietary extended-release pellet implants), and supervised medical detoxification—billed on a cash-pay basis without insurance. The practice also provides a proprietary naltrexone nasal spray for fentanyl overdose and medical-legal consultation services for attorneys and courts.

Product overview

Addiction Medicine Practice offers a comprehensive suite of medication-assisted addiction treatment services rather than a unified software platform. The core offerings center on opioid addiction treatment via three main modalities: Suboxone/Subutex (buprenorphine) maintenance therapy, Naltrexone maintenance therapy (available as oral pills, monthly injectable Vivitrol, and implantable pellets), and detoxification programs. Additional services include alcohol detox (using disulfiram/Antabuse), smoking cessation (using Chantix/varenicline), cocaine and methamphetamine aversion therapy (off-label disulfiram/naltrexone combination), process addictions including sex and gambling (naltrexone therapy), and medical-legal consultation. The practice also provides a proprietary naltrexone nasal spray as a fentanyl antidote. Pricing varies by service with office consultations at $150, detox programs from $300-$375, and naltrexone maintenance ranging from $150 monthly (oral) to $400-$600 for implants every 2-3 months.

Differentiator

Problem solved

Functional benefit

Products and services

• Suboxone (or Subutex) Maintenance Therapy Medication-assisted treatment using buprenorphine (Suboxone/Subutex) for opioid addiction maintenance. Patients undergo induction, stabilization, and maintenance phases with ongoing monitoring, priced at $150/month.
• Naltrexone Maintenance Therapy Long-acting opioid blockade treatment using naltrexone in oral, injectable, and pellet implant forms to prevent relapse. Includes oral naltrexone ($150/month), injectable naltrexone palmitate ($300/month), and Vivitrol ($100/month with insurance, $1,250/month without).
• Opiate Detoxification Medically supervised detoxification from opioids including heroin, Vicodin, Percocet, and OxyContin using medication protocols to manage withdrawal symptoms, priced at $375.
• Alcohol Detoxification Medical treatment for alcohol addiction using disulfiram (Antabuse) to create aversive reactions when alcohol is consumed and reduce cravings, priced at $300.
• Methadone Detoxification Detoxification program transitioning patients from methadone to Suboxone (or Subutex), followed by naltrexone to maintain opioid blockade.
• Smoking Cessation / Nicotine Treatment Smoking cessation program using varenicline (Chantix), a partial nicotine agonist that blocks nicotine effects and alleviates withdrawal symptoms, priced at $100/month.
• Cocaine Aversion Therapy Off-label treatment using disulfiram (Antabuse) and naltrexone (Revia) combination to create aversion to cocaine and reduce cravings.
• Methamphetamine Aversion Therapy Off-label treatment using disulfiram (Antabuse) and naltrexone (Revia) combination for methamphetamine addiction, based on similar mechanism of action to cocaine treatment.
• Fentanyl Antidote (Naltrexone Nasal Spray) Proprietary naltrexone nasal spray for fentanyl overdose reversal, designed to immediately restore breathing and detoxify overdose victims. Provided free with first visit; $50 otherwise. Continued monthly injections or pellet implantation prevent re-narcotization.
• Sex Addiction Treatment Process addiction treatment using naltrexone therapy in combination with 12-step recovery programs for sex addiction.
• Gambling Addiction Treatment Process addiction treatment using naltrexone therapy for gambling addiction, as pathological gambling responds to opioid antagonist medication.
• Medical-Legal Consultation Legal consultation services including monitoring, document review, report preparation, and expert testimony for addiction-related legal matters, provided to attorneys, courts, and legal professionals.
• Naltrexone Pellet Implants Surgically implanted naltrexone pellets (500mg for 2 months at $400, or 800mg for 3 months at $600) providing sustained-release opioid blockade via subcutaneous insertion.
• Sublocade (Monthly Injectable Buprenorphine) Monthly injectable buprenorphine (Sublocade) formulation for opioid use disorder maintenance, priced at $150/month.
• Office Consultation Initial patient consultation for addiction assessment and treatment planning, priced at $150 per visit.

Quantifiable outcome

• Average time to heroin relapse: 115 days for oral naltrexone vs. 158 days for implant patients
• +3 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Acadia Healthcare: Large publicly traded behavioral health provider with inpatient and outpatient substance abuse treatment programs; overlaps in addiction services but operates at vastly different scale.
• Caron Treatment Centers: Established nonprofit addiction treatment provider offering residential, outpatient, and MAT services including naltrexone protocols; comparable clinical offerings at larger, multi-modality scale.
• Hazelden Betty Ford Foundation: Major nonprofit addiction treatment organization with outpatient MAT, residential programs, and naltrexone-based protocols; comparable breadth across addiction types and modalities.

Emerging players

• Eleanor Health: Tech-enabled outpatient MAT and mental health provider combining in-person and virtual care; competes for the same opioid/alcohol addiction patients with a digital-first delivery model.
• Workit Health: Telehealth-based MAT provider offering buprenorphine and naltrexone treatment online; represents the digital-native competitor the subject's traditional office model cannot easily replicate.
• Ophelia Health: Telehealth MAT provider focused on buprenorphine treatment for opioid use disorder via remote consultations; emerging digital competitor in the same patient segment.

Direct peers

• CleanSlate Centers: Multi-site outpatient MAT provider offering buprenorphine and naltrexone-based addiction treatment with similar medication modalities and patient self-pay/insurance mix.
• BrightView Health: Outpatient addiction treatment company delivering MAT (Suboxone, Vivitrol) and counseling across multiple states with comparable service mix and clinical staffing model.
• Ideal Option: Outpatient MAT network offering buprenorphine and naltrexone maintenance for opioid and alcohol use disorders, closely aligned with the subject's Suboxone/naltrexone service model.

Others

• Alkermes (Vivitrol manufacturer): Pharmaceutical company that developed and markets Vivitrol (monthly injectable naltrexone), a product the subject practice directly administers; comparable via shared naltrexone-based treatment paradigm.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Addiction Medicine Practice